Forms of Nimesulide

Nimesuilde is a pain killer NSAIDs drug is the best prescribed drug for treatment of acute pain, Primary
dysmennorhea and also to treat degenerative joint disease.
Nimesulide drug was launched in Italy for the first time as Aulin and Mesulid in 1985 and is presently
available in more than 50 countries worldwide with different trademarks.
Its multifactorial mode of action gives it a unique and broad action on inflammatory processes.
It has superior gastrointestinal safety as compared to other NSAIDs. It is an analgesic and antipyretic in
action, other than its anti inflammatory action.
Unlike, other NSAIDs, the chemical structure of nimesulide does not contain a carboxylic group but a
sulfonanilide moiety as the acidic group.
Apart from tablet the drug- Nimesulide is also available in various forms such as in the form of Gell,
powder, and suppositories. Its also available in various brand names of Sulide, Nimalox, Nimesil,
Nimulid, Nicip, Nimcap, Nise, Sulidene and Zolan e.t.c.
The Nimulid Transgel a brand from Nimesulide Transdermal Gel is indicated for post-traumatic
inflammation, acute musculoskeletal disorders including sprains, strains, tendinitis, tenosynovitis, low
back pain, periarthritis (shoulder pain) and osteoarthritis (joint pains), stiffness.
As with all drugs, therapy appropriateness when using nimesulide is of outmost importance to safeguard
patients health and guarantee the products therapeutic value.
NImesulide is available in the dosage of 100 mgs for tablets, 100 mg for granules for oral suspension,
200mg for suppositories and 3% of gel. And the prescribed duration to use is for 15 days.
Continuous use of NImesulide may cause cetain side effects like Diarrhea, vomiting, skin rash e.t.c, It
also preffered to use for the age above 12. Women should use the drug with caution during lactation
and it is contraindicated during pregnancy.
It must be used under supervision by a doctor in accordance with the approved indications and in
compliance with the recommendations
The prescription of a drug is appropriate when the benefit it is able to provide to a specific patient
outweigh the risks associated with its use. A careful evaluation of individual risk factors is therefore of
crucial importance.

In practice, a prescription can be considered appropriate when it is in accordance with the approved
indications of a drug in terms of demonstrated efficacy, dosage, and treatment duration.

Nimesulide should only be prescribed as second line treatment. The decision to prescribe nimesulide
should be based on assessment of the individual patients overall risks.
Nimesulide's therapeutic value in effectively and rapidly controlling inflammation and pain is supported
by significant clinical evidence.
Clinical studies have been carried out in a wide variety of acute inflammatory and painful conditions
with the aim of evaluating the analgesic activity of nimesulide in comparison to placebo and to some of
the most common NSAIDs.
In these studies, it is observed that the efficacy of nimesulide was consistently superior to placebo with
a particularly fast onset of the analgesic in action.
The rapid action shows the immediate relief within the 15 min from the drug intake for the acute pain.


Keywords:
Nimesulide tablets, Nimesulide Gel, Nimesulide Pain Relief, Nimesulide Brands, Nimesulide forms,
Nimesulide for joint painrelief, Nimesulide Powder, NImesulide drug, NSAIDs drug nimesulide


1. Nimesulide Drug
2. Nimesulide dose
3. Nimesulide dosage
4. Nimesulide usage
5. Nimesulide advantages.
6. Nimesulide Benefits.
7. Nimesulide 100mg
8. Nimesulide gel.
9. Nimesulide and paracetamol.
10. Nimesulide Tablets
11.Nimesulide Solubility
12. Nimesulide in Pain
13. Nimesulide brands
14. Nimesulide efficacy
15. Nimesulide safety
16. Nimesulide actions
17. Nimesulide Forms
18. Nimesulide Pill
19. Nimesulide for Pain Relief
20. Nimesulide Medicine


Nimesulide drug was launched in Italy for the first time as Aulin and Mesulid in 1985 and is presently
available in more than 50 countries worldwide with different trademarks.

Nimesulide is a relatively COX-2 selective, non-steroidal anti-inflammatory drug (NSAID) with analgesic
and antipyretic properties.

Nimesulide is a prescription non-steroidal anti-inflammatory drug with a multifactorial mode of action
for the treatment of for post-traumatic inflammation, acute musculoskeletal disorders including sprains,
strains, tendinitis, tenosynovitis, low back pain, periarthritis (shoulder pain) and osteoarthritis (joint
pains), stiffness.

It has superior gastrointestinal safety as compared to other NSAIDs.
It is an analgesic and antipyretic in action. Its multifactorial mode of action gives it a unique and broad
action on inflammatory processes.

The maximum duration and dose of a treatment course with Nimesulide medicine is 15 days, 100 mg
twice a day, to minimize the risk of hepatotoxicity.

It undergoes extensive biotransformation.

NImesulide is available in the dosage of 100 mgs for tablets, 100 mg for granules for oral suspension,
200mg for suppositories and 3% of gel. And the prescribed duration to use is for 15 days.

Clinical studies have been carried out in a wide variety of acute inflammatory and painful conditions
with the aim of evaluating the analgesic activity of nimesulide in comparison to placebo and to some of
the most common NSAIDs.

In these studies, the efficacy of nimesulide was consistently superior to placebo with a particularly fast
onset of the analgesic action.

This rapid onset of analgesic action shows meaningful reductions in pain and inflammation observed
within 15 minutes from drug intake.

Continuous use of NImesulide may cause cetain side effects like Diarrhea, vomiting, skin rash e.t.c, It
also preffered to use for the age above 12. Women should use the drug with caution during lactation
and it is contraindicated during pregnancy.

It must be used under supervision by a doctor in accordance with the approved indications and in
compliance with the recommendations
The prescription of a drug is appropriate when the benefit it is able to provide to a specific patient
outweigh the risks associated with its use. A careful evaluation of individual risk factors is therefore of
crucial importance.

In practice, a prescription can be considered appropriate when it is in accordance with the approved
indications of a drug in terms of demonstrated efficacy, dosage, and treatment duration.

Nimesulide should only be prescribed as second line treatment. The decision to prescribe nimesulide
should be based on assessment of the individual patients overall risks.

Nimesulide's therapeutic value in effectively and rapidly controlling inflammation and pain is supported
by significant clinical evidence.

Food, gender and advanced age have negligible effects on nimesulide pharmacokinetics.

SIDE EFFECTS:

The use of nimesulide in children under the age of 12 is contraindicated.[citation needed]. Continuous
use of nimesulide (more than 15 days) can cause the following side effects:

Diarrhea
Vomiting
Skin rash
Pruritis
Dizziness
Bitterness in mouth

Women should use the drug with caution during lactation and it is contraindicated during pregnancy.